Found: 5
Select item for more details and to access through your institution.
Tumor-infiltrating CCR2<sup>+</sup> inflammatory monocytes counteract specific immunotherapy.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1267866
- By:
- Publication type:
- Article
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1238861
- By:
- Publication type:
- Article
Author Correction: Dithranol as novel co-adjuvant for non-invasive dermal vaccination.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Dithranol as novel co-adjuvant for non-invasive dermal vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00530-9
- By:
- Publication type:
- Article
Quantifying cell disruption as an integral part of natural product extraction.
- Published in:
- Food & Bioproducts Processing: Transactions of the Institution of Chemical Engineers Part C, 2019, v. 117, n. Part C, p. 84, doi. 10.1016/j.fbp.2019.06.013
- By:
- Publication type:
- Article